V. K. Arora

Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India

OBJECTIVEnTo assess the cost and cost-effectiveness of the Public-Private Mix DOTS (PPM-DOTS) strategy for tuberculosis (TB) control in India.nnnMETHODSnWe collected data on the costs and effects of pilot PPM-DOTS projects in Delhi and Hyderabad using documentary data and interviews. The cost of PPM-DOTS was compared with public sector DOTS (i.e. DOTS delivered through public sector facilities only) and non-DOTS treatment in the private sector. Costs for 2002 in US

Amplification of Hsp 65 gene and usage of restriction endonuclease for identification of non tuberculous rapid grower mycobacterium

were assessed for the public sector, private practitioners, and patients/attendants. Effectiveness was measured as the number of cases successfully treated.nnnFINDINGSnThe average cost per patient treated was US

Virtual ICU and E-learning tools: Scope in critical care medicine in India

111-123 for PPM-DOTS and public sector DOTS, and US

Tuberculosis and other chronic morbidity profile of sewage workers of Delhi

111-172 for non-DOTS treatment in the private sector. From the public sectors perspective, the cost per patient treated was lower in PPM-DOTS projects than in public sector DOTS programmes (US

Prevalence & pattern of respiratory diseases including Tuberculosis in elderly in Ghaziabad – Delhi – NCR

24-33 versus US

Viewpoint: Is it right time for undergraduate curriculum change based on our National Health Programmes – Tuberculosis Programme a perfect example?

63). DOTS implementation in either the public or private sectors improved treatment outcomes and substantially lowered costs incurred by patients and their attendants, compared to non-DOTS treatment in the private sector (US

DOTS-plus for patients with multidrug-resistant tuberculosis in India : Early results after three years

50-60 for DOTS compared to over US

Influence of pre-treatment bacillary load on treatment outcome of pulmonary tuberculosis patients receiving DOTS under revised national tuberculosis control programme.

100 for non-DOTS). The average cost-effectiveness of PPM-DOTS and public sector DOTS was similar, at US

Endobronchial tuberculosis presenting as tumorous mass.

120-140 per patient successfully treated, compared to US

Cost and Cost-Effectiveness of PPM-DOTS for Tuberculosis Control: Evidence from India/Cout et Rapport Cout/ Efficacite De la Strategie PPM-DOTS Dans la Lutte Contre la Tuberculose: Resultats Obtenus En Inde/Costo Y Costoeficacia De la DOTS-PP Contra la Tuberculosis: Datos De la India

218-338 for non-DOTS private sector treatment. Incremental cost-effectiveness analysis showed that PPM-DOTS can improve effectiveness while also lowering costs.nnnCONCLUSIONnPPM-DOTS can be an affordable and cost-effective approach to improving TB control in India, and can substantially lower the economic burden of TB for patients.